Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-28

FDA Approved: CURIST ACID RELIEF — Supplemental Application (Little Pharma, Inc.)

View source ↗

Summary

FDA granted a supplemental approval for Curist Acid Relief containing famotidine 20 mg from Little Pharma, Inc., updating the ANDA with the approved dosage form…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CURIST ACID RELIEF (famotidine)

Snippet

SUPPL AP for CURIST ACID RELIEF (FAMOTIDINE 20 MG)